Bofanglutide linked to meaningful reductions in HbA1c in adults with T2DM
For adults with type 2 diabetes mellitus (T2DM), bofanglutide, a glucagon-like peptide-1 receptor agonist, is associated with more meaningful reductions in hemoglobin A1C (HbA1c) levels than semaglutide, according to a study ...
Jul 2, 2026
0
4









